{"id":6746,"date":"2026-07-17T10:04:44","date_gmt":"2026-07-17T08:04:44","guid":{"rendered":"https:\/\/stopalzheimer.be\/?p=6746"},"modified":"2026-07-17T10:04:47","modified_gmt":"2026-07-17T08:04:47","slug":"trontinemab-essai-clinique-stop-alzheimer","status":"publish","type":"post","link":"https:\/\/stopalzheimer.be\/nl\/trontinemab-essai-clinique-stop-alzheimer\/","title":{"rendered":"Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\"><strong>Maladie d\u2019Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Une avanc\u00e9e majeure est en cours dans la lutte contre la maladie d\u2019Alzheimer. Un essai clinique de phase 3 explorera prochainement la possibilit\u00e9 d\u2019intervenir chez des personnes \u00e0 haut risque de d\u00e9velopper la maladie, avant m\u00eame l\u2019apparition des premiers sympt\u00f4mes perceptibles par l\u2019entourage.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cet essai repose sur une innovation r\u00e9cente et d\u00e9terminante : l\u2019identification pr\u00e9coce des patients gr\u00e2ce \u00e0 des marqueurs sanguins. Ces tests permettent aujourd\u2019hui de d\u00e9tecter, de fa\u00e7on non invasive, les signes biologiques de la maladie plusieurs ann\u00e9es avant l\u2019apparition des troubles de m\u00e9moire ou des changements de comportement, notamment dans les cliniques de la m\u00e9moire et les centres de recherche universitaires belges.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019essai PrevenTRON, pr\u00e9sent\u00e9 \u00e0 l\u2019AAIC 2026, pr\u00e9voit d\u2019inclure 1.600 personnes cognitivement indemnes identifi\u00e9es comme \u00e0 haut risque de progression vers une forme symptomatique d\u2019Alzheimer gr\u00e2ce \u00e0 un biomarqueur sanguin, le pTau217. L\u2019objectif principal est de mesurer le temps jusqu\u2019\u00e0 la progression clinique confirm\u00e9e, afin d\u2019\u00e9valuer si le traitement peut r\u00e9ellement retarder l\u2019apparition des sympt\u00f4mes.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019ambition de ce traitement d\u00e9passe donc les approches th\u00e9rapeutiques actuelles. Il ne s\u2019agit plus uniquement de ralentir ou d\u2019att\u00e9nuer les sympt\u00f4mes, mais bien d\u2019agir en amont. Cette derni\u00e8re phase de l\u2019essai clinique vise \u00e0 d\u00e9montrer qu\u2019il est possible de retarder, voire d\u2019emp\u00eacher, l\u2019apparition des sympt\u00f4mes cliniques qui impactent le quotidien des patients et de leurs proches.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00ab <em>Nous sommes \u00e0 un moment charni\u00e8re<\/em> \u00bb, souligne la Fondation Stop Alzheimer, engag\u00e9e dans le financement de la recherche scientifique en Belgique depuis 1995. \u00ab <em>Gr\u00e2ce aux progr\u00e8s du diagnostic, notamment via les biomarqueurs sanguins, il devient possible d\u2019identifier les personnes \u00e0 risque \u00e9lev\u00e9 bien avant les premiers signes visibles. Cela ouvre la voie \u00e0 des traitements qui visent \u00e0 pr\u00e9venir l\u2019expression de la maladie, et non plus seulement \u00e0 en att\u00e9nuer les effets.<\/em> \u00bb<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La phase 3 constitue la derni\u00e8re \u00e9tape avant une \u00e9ventuelle mise sur le march\u00e9. Elle doit confirmer, \u00e0 grande \u00e9chelle, l\u2019efficacit\u00e9 et la s\u00e9curit\u00e9 du traitement chez des patients pr\u00e9sentant un risque avanc\u00e9 de d\u00e9velopper la maladie d\u2019Alzheimer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pour la Fondation Stop Alzheimer, cet essai illustre une transformation profonde de la recherche : \u00ab <em>Nous passons progressivement d\u2019une m\u00e9decine r\u00e9active \u00e0 une m\u00e9decine anticipative. C\u2019est une \u00e9volution fondamentale, rendue possible gr\u00e2ce \u00e0 des ann\u00e9es d\u2019investissements dans la recherche et \u00e0 la mobilisation de nos donateurs.<\/em> \u00bb<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/stopalzheimer.be\/fr\/prevalence-stop-alzheimer\/\">Alors qu\u2019une augmentation de plus de 64% du nombre de cas de la maladie d\u2019Alzheimer est attendue en Belgique d\u2019ici 2050<\/a>, cette approche pourrait, \u00e0 terme, changer radicalement la trajectoire de la maladie \u2014 en intervenant avant que les sympt\u00f4mes ne bouleversent la vie des patients et de leurs familles.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c0 l\u2019heure o\u00f9 la recherche franchit des \u00e9tapes d\u00e9cisives, ces avanc\u00e9es ne pourront toutefois pleinement se concr\u00e9tiser sans un engagement fort des pouvoirs publics. \u00ab <em>Les progr\u00e8s sont r\u00e9els, rapides et porteurs d\u2019espoir, mais ils doivent imp\u00e9rativement s\u2019accompagner d\u2019une prise de conscience politique<\/em> \u00bb, insiste la Fondation Stop Alzheimer. <em>\u00ab Investir dans le diagnostic pr\u00e9coce, soutenir les essais cliniques et anticiper l\u2019acc\u00e8s aux futurs traitements sont des enjeux de sant\u00e9 publique majeurs. Sans une mobilisation \u00e0 la hauteur, le potentiel de ces avanc\u00e9es risque de rester sous-exploit\u00e9.<\/em> \u00bb<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019enjeu est d\u00e9sormais clair : transformer ces progr\u00e8s scientifiques en solutions concr\u00e8tes pour les patients, avant que la maladie ne s\u2019impose comme l\u2019un des plus grands d\u00e9fis sanitaires des prochaines d\u00e9cennies.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Maladie d\u2019Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles Une avanc\u00e9e majeure est en cours dans la lutte contre la maladie d\u2019Alzheimer. Un essai clinique de phase 3 explorera prochainement la possibilit\u00e9 d\u2019intervenir chez des personnes \u00e0 haut risque de d\u00e9velopper la maladie, avant m\u00eame [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":1446,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4,29],"tags":[],"locatie":[27,26,28,41],"class_list":["post-6746","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actie-in-de-kijker","category-onderzoek","locatie-help-mee","locatie-homepage","locatie-over-alzheimer","locatie-pers"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles - Stop Alzheimer<\/title>\n<meta name=\"description\" content=\"Quelle possibilit\u00e9 d\u2019intervenir chez des patients \u00e0 haut risque de d\u00e9velopper Alzheimer, avant m\u00eame l\u2019apparition des sympt\u00f4mes visibles.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stopalzheimer.be\/nl\/trontinemab-essai-clinique-stop-alzheimer\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles - Stop Alzheimer\" \/>\n<meta property=\"og:description\" content=\"Quelle possibilit\u00e9 d\u2019intervenir chez des patients \u00e0 haut risque de d\u00e9velopper Alzheimer, avant m\u00eame l\u2019apparition des sympt\u00f4mes visibles.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stopalzheimer.be\/nl\/trontinemab-essai-clinique-stop-alzheimer\/\" \/>\n<meta property=\"og:site_name\" content=\"Stop Alzheimer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StichtingAlzheimerOnderzoek\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-17T08:04:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-17T08:04:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stopalzheimer.be\/wp-content\/uploads\/2023\/10\/15.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lucie\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lucie\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/\"},\"author\":{\"name\":\"Lucie\",\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/#\\\/schema\\\/person\\\/b3d2b971281990e02698b8b4977349d4\"},\"headline\":\"Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles\",\"datePublished\":\"2026-07-17T08:04:44+00:00\",\"dateModified\":\"2026-07-17T08:04:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/\"},\"wordCount\":640,\"publisher\":{\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stopalzheimer.be\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/15.jpg\",\"articleSection\":[\"Actie in de kijker\",\"Onderzoek\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/\",\"url\":\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/\",\"name\":\"Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles - Stop Alzheimer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stopalzheimer.be\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/15.jpg\",\"datePublished\":\"2026-07-17T08:04:44+00:00\",\"dateModified\":\"2026-07-17T08:04:47+00:00\",\"description\":\"Quelle possibilit\u00e9 d\u2019intervenir chez des patients \u00e0 haut risque de d\u00e9velopper Alzheimer, avant m\u00eame l\u2019apparition des sympt\u00f4mes visibles.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stopalzheimer.be\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/15.jpg\",\"contentUrl\":\"https:\\\/\\\/stopalzheimer.be\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/15.jpg\",\"width\":1200,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/trontinemab-essai-clinique-stop-alzheimer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stopalzheimer.be\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/\",\"name\":\"Stop Alzheimer\",\"description\":\"Stichting Alzheimer Onderzoek\",\"publisher\":{\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/#organization\",\"name\":\"Stop Alzheimer\",\"url\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stopalzheimer.be\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/241021_Alzheimer_logoNL_NEW.png\",\"contentUrl\":\"https:\\\/\\\/stopalzheimer.be\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/241021_Alzheimer_logoNL_NEW.png\",\"width\":2362,\"height\":515,\"caption\":\"Stop Alzheimer\"},\"image\":{\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/StichtingAlzheimerOnderzoek\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@stichtingalzheimeronderzoe3860\\\/videos\",\"https:\\\/\\\/be.linkedin.com\\\/in\\\/stichting-alzheimer-onderzoek-fondation-recherche-alzheimer-8760b61a4\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stopalzheimer.be\\\/fr\\\/#\\\/schema\\\/person\\\/b3d2b971281990e02698b8b4977349d4\",\"name\":\"Lucie\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a2cabf71da3f66ce28610368d66eab36ec2a054b07526e0376fc3565112668b7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a2cabf71da3f66ce28610368d66eab36ec2a054b07526e0376fc3565112668b7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a2cabf71da3f66ce28610368d66eab36ec2a054b07526e0376fc3565112668b7?s=96&d=mm&r=g\",\"caption\":\"Lucie\"},\"url\":\"https:\\\/\\\/stopalzheimer.be\\\/nl\\\/author\\\/lucie\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles - Stop Alzheimer","description":"Quelle possibilit\u00e9 d\u2019intervenir chez des patients \u00e0 haut risque de d\u00e9velopper Alzheimer, avant m\u00eame l\u2019apparition des sympt\u00f4mes visibles.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stopalzheimer.be\/nl\/trontinemab-essai-clinique-stop-alzheimer\/","og_locale":"nl_NL","og_type":"article","og_title":"Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles - Stop Alzheimer","og_description":"Quelle possibilit\u00e9 d\u2019intervenir chez des patients \u00e0 haut risque de d\u00e9velopper Alzheimer, avant m\u00eame l\u2019apparition des sympt\u00f4mes visibles.","og_url":"https:\/\/stopalzheimer.be\/nl\/trontinemab-essai-clinique-stop-alzheimer\/","og_site_name":"Stop Alzheimer","article_publisher":"https:\/\/www.facebook.com\/StichtingAlzheimerOnderzoek\/","article_published_time":"2026-07-17T08:04:44+00:00","article_modified_time":"2026-07-17T08:04:47+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/stopalzheimer.be\/wp-content\/uploads\/2023\/10\/15.jpg","type":"image\/jpeg"}],"author":"Lucie","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"Lucie","Geschatte leestijd":"3 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/#article","isPartOf":{"@id":"https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/"},"author":{"name":"Lucie","@id":"https:\/\/stopalzheimer.be\/fr\/#\/schema\/person\/b3d2b971281990e02698b8b4977349d4"},"headline":"Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles","datePublished":"2026-07-17T08:04:44+00:00","dateModified":"2026-07-17T08:04:47+00:00","mainEntityOfPage":{"@id":"https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/"},"wordCount":640,"publisher":{"@id":"https:\/\/stopalzheimer.be\/fr\/#organization"},"image":{"@id":"https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/#primaryimage"},"thumbnailUrl":"https:\/\/stopalzheimer.be\/wp-content\/uploads\/2023\/10\/15.jpg","articleSection":["Actie in de kijker","Onderzoek"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/","url":"https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/","name":"Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles - Stop Alzheimer","isPartOf":{"@id":"https:\/\/stopalzheimer.be\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/#primaryimage"},"image":{"@id":"https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/#primaryimage"},"thumbnailUrl":"https:\/\/stopalzheimer.be\/wp-content\/uploads\/2023\/10\/15.jpg","datePublished":"2026-07-17T08:04:44+00:00","dateModified":"2026-07-17T08:04:47+00:00","description":"Quelle possibilit\u00e9 d\u2019intervenir chez des patients \u00e0 haut risque de d\u00e9velopper Alzheimer, avant m\u00eame l\u2019apparition des sympt\u00f4mes visibles.","breadcrumb":{"@id":"https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/#primaryimage","url":"https:\/\/stopalzheimer.be\/wp-content\/uploads\/2023\/10\/15.jpg","contentUrl":"https:\/\/stopalzheimer.be\/wp-content\/uploads\/2023\/10\/15.jpg","width":1200,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/stopalzheimer.be\/trontinemab-essai-clinique-stop-alzheimer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stopalzheimer.be\/"},{"@type":"ListItem","position":2,"name":"Alzheimer : un essai clinique de phase 3 cible les personnes \u00e0 risque avant les premiers sympt\u00f4mes visibles"}]},{"@type":"WebSite","@id":"https:\/\/stopalzheimer.be\/fr\/#website","url":"https:\/\/stopalzheimer.be\/fr\/","name":"Stop Alzheimer","description":"Stichting Alzheimer Onderzoek","publisher":{"@id":"https:\/\/stopalzheimer.be\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stopalzheimer.be\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/stopalzheimer.be\/fr\/#organization","name":"Stop Alzheimer","url":"https:\/\/stopalzheimer.be\/fr\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/stopalzheimer.be\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/stopalzheimer.be\/wp-content\/uploads\/2025\/04\/241021_Alzheimer_logoNL_NEW.png","contentUrl":"https:\/\/stopalzheimer.be\/wp-content\/uploads\/2025\/04\/241021_Alzheimer_logoNL_NEW.png","width":2362,"height":515,"caption":"Stop Alzheimer"},"image":{"@id":"https:\/\/stopalzheimer.be\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StichtingAlzheimerOnderzoek\/","https:\/\/www.youtube.com\/@stichtingalzheimeronderzoe3860\/videos","https:\/\/be.linkedin.com\/in\/stichting-alzheimer-onderzoek-fondation-recherche-alzheimer-8760b61a4"]},{"@type":"Person","@id":"https:\/\/stopalzheimer.be\/fr\/#\/schema\/person\/b3d2b971281990e02698b8b4977349d4","name":"Lucie","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/secure.gravatar.com\/avatar\/a2cabf71da3f66ce28610368d66eab36ec2a054b07526e0376fc3565112668b7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2cabf71da3f66ce28610368d66eab36ec2a054b07526e0376fc3565112668b7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2cabf71da3f66ce28610368d66eab36ec2a054b07526e0376fc3565112668b7?s=96&d=mm&r=g","caption":"Lucie"},"url":"https:\/\/stopalzheimer.be\/nl\/author\/lucie\/"}]}},"_links":{"self":[{"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/posts\/6746","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/comments?post=6746"}],"version-history":[{"count":1,"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/posts\/6746\/revisions"}],"predecessor-version":[{"id":6747,"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/posts\/6746\/revisions\/6747"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/media\/1446"}],"wp:attachment":[{"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/media?parent=6746"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/categories?post=6746"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/tags?post=6746"},{"taxonomy":"locatie","embeddable":true,"href":"https:\/\/stopalzheimer.be\/nl\/wp-json\/wp\/v2\/locatie?post=6746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}